Tenzing in its latest 8-K filing released an investor presentation highlighting Reviva Pharmaceuticals. A shareholder vote on the SPAC’s proposed merger with Reviva is set for Dec. 8. Read more.
Tenzing Releases Investor Presentation on Reviva
Related Posts
Oxbridge Wants Another 9 Months to Seal a Deal
The SPAC raised $100 million in an August 2021 IPO with plans to concentrate on disruptive Insurtech companies.
Banner Acquisition Registers for $150M IPO
The new SPAC in the filing said it intends "to initially focus on companies with an enterprise value range of $500 million to $3 billion, depending on market opportunities for liquidity, that have strong historical earnings and are essential to the United States economy." This includes healthcare, education and business services.
Union Acquisition II Discloses Redemptions of More Than 50% Ahead of Today’s Procaps Vote
Union Acquisition II in an 8-K filing revealed that more than 7.7 million of its 13.55 million ordinary shares were submitted for redemption ahead of the SPAC's merger vote on Procaps that was scheduled for this morning.
Nasdaq Puts Aetherium Acquisition on Notice for Delisting
The Asia-focused SPAC raised $116.7 million in a July 2021 IPO to target EdTech companies, although redemptions in the nearly two years since have eaten away at the trust., which has fallen below the Nasdaq's $50 million market cap threshold.